Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2000
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046038A1 Use of mass fingerprinting for identification of protein affinity ligands
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045857A1 MULTIPLE DRUG RESISTANCE GENE atrC OF ASPERGILLUS NIDULANS
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/24/2000US6136969 Azepanes
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136584 Joining polypeptide; for the development of and screening of therapy agents for autoimmune diseases
10/24/2000US6136583 Amidase
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136565 Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136562 Synthetic dna which encodes a peptide having a defined amino acid sequence; for recombinant production of the peptide for use in cattle; veterinary medicine
10/24/2000US6136557 Strepococcus pneumoniae gene sequence FtsH
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136544 Amino acid sequence of unedited form of human excitatory amino acid 4 receptor subunit; for drug screening
10/24/2000US6136536 Recombinant dna sequence from plasmid phtop; for production in chinese hamster ovary cell lines
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136526 Use of human neutrophil lipocalin (HNL) as a diagnostic marker and anti-HNL-antibody preparation
10/24/2000US6136313 Processes and intermediates for synthetic antibody derivatives
10/24/2000US6136311 Using monoclonal antibodies
10/24/2000US6136310 Recombinant anti-CD4 antibodies for human therapy
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000CA2147541C Preparation process of a natural protein sweetener
10/24/2000CA2061569C Improved activation of recombinant proteins
10/24/2000CA1341124C Genetic engineering process for the preparation of hirudins, and means for carrying out this process
10/19/2000WO2000062062A1 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061768A2 Preparation of biologically active molecules
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061761A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061739A1 Method for controlling the activity of immunologically functional molecule
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061728A2 Human elastase i
10/19/2000WO2000061727A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
10/19/2000WO2000061725A1 Method of purifying heterologous proteins
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061637A1 Erythropoietin receptor antibodies
10/19/2000WO2000061635A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061626A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061618A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/19/2000WO2000061165A1 Conserved adhesin motif and methods of use thereof
10/19/2000WO2000036093A3 Intein-mediated cyclization of peptides
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000WO2000031279A3 Producing antimicrobial cationic peptides as fusion proteins
10/19/2000WO2000028067A9 Enzymatic amidation of peptides
10/19/2000DE19916242A1 PSA-haltige Substanz und deren Verwendung PSA-containing substance and its use
10/19/2000DE19915938A1 Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung Production of pancreatic procarboxypeptidase B isoforms and its muteins and their use
10/19/2000DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use
10/19/2000CA2704600A1 A method for producing antibodies with increased adcc activity
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371941A1 Method of purifying heterologous proteins
10/19/2000CA2371929A1 Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370562A1 49 human secreted proteins
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370489A1 49 human secreted proteins
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2370131A1 62 human secreted proteins
10/19/2000CA2370112A1 Uncoupling proteins
10/19/2000CA2369892A1 Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same
1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 1125